COPD

>

Latest News

Find and Treat Asthma and COPD: All Interventions Make a Difference, Study Concludes ©Crystal Light/stock.adobe.com
Find and Treat Asthma and COPD: All Interventions Make a Difference, Study Concludes

May 22nd 2024

Adults with undiagnosed asthma or COPD who were randomly detected and assigned to specialist or usual care all had improved outcomes at 1 year, Canadian authors reported.

Dupilumab reduced annualized rate of exacerbations in COPD in NOTUS Surya P Bhatt, MD, MSPH Courtesy University of Alabama
Dupilumab in Replicate Phase 3 Trial Significantly Reduces COPD Exacerbations, Improves Lung Function, with PDUFA Date in Sight

May 21st 2024

Tezepelumab Reduces COPD Exacerbations, Improves Lung Function in Phase 2a COURSE Trial ©MichaelVi/stock.adobe.com
Tezepelumab Reduces Rate of COPD Exacerbations in Individuals with Wide Range of Blood Eosinophil Levels: Phase 2a COURSE Trial Findings

May 20th 2024

Budesonide-Based Triple Therapy Most Effective vs Dual Therapy for COPD / image credit Breztri Aeorsphere package couretesy of AstraZeneca
Budesonide-Based Triple Therapy Most Cost-Effective vs Dual Therapy for COPD

May 9th 2024

©Oleksandr/stock.adobe.com via AI
AstraZeneca at ATS 2024: Look for Late-Breaking Data on Novel Therapeutics for COPD

May 8th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.